AI system shows high accuracy for diabetic retinopathy screening
"AI could help reduce the burden on ophthalmology services by triaging large numbers of patients with diabetes and allowing specialists to focus on those who most urgently need care."
An AI-based system accurately identifies referable diabetic retinopathy in routine clinical practice, as shown in a study published in Nature.
2
The system analyzes non-mydriatic fundus photographs to detect diabetic retinopathy and diabetic macular edema, reducing reliance on specialist graders.
3
The AI screening maintained very high diagnostic accuracy, exceeding regulatory benchmarks for sensitivity and specificity in a real-world hospital setting.
4
The study found strong agreement between AI and human grading, supporting the operational feasibility of AI for diabetic retinopathy screening.
5
AI systems are designed to support clinical expertise, helping triage screening images and allowing ophthalmologists to focus on advanced cases.
AACE Endocrine AI
is published by Conexiant under a license arrangement with the American Association of Clinical Endocrinology, Inc. (AACE®). The ideas and opinions expressed in
AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. For more information, see Policies.